Adverse Events, Comorbidities, and HIVNews Analysis

We Need to Temper Expectations for Remdesivir as COVID-19 Treatment

Fauci discusses Remdesivir
Anthony Fauci, M.D., the director of the National Institute of Allergy and Infectious Diseases, discusses early study results regarding remdesivir during a meeting with U.S. President Donald Trump and Louisiana Gov. John Bel Edwards on April 29 in the Oval Office.Doug Mills via GettyImages
    Kenyon Farrow

    Kenyon Farrow


    Kenyon was the senior editor of TheBody/TheBodyPro from 2017 to 2020. He is the co-executive director of Partners for Dignity & Rights, a U.S. organization advocating for social and systemic justice.